ISRCTN15806146
Completed
Not Applicable
The effect of modulating gut microflora on clinical outcome in elective surgical patients.
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 sites80 target enrollmentSeptember 30, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Using bacterial translocation as the primary end point for sample size calculation, if the sample size in each of the 4 groups is 20, alpha\=0\.05 (2\-tailed) a chi\-square test will have 80% power to detect a difference in proportions.
Exclusion Criteria
- •Failure to obtain informed consent, patients with co\-existing infections, patients on antibiotics in the previous 2 weeks before recruitment and patients with severe hepatic or renal failure.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study on changes in gut microbiota and the effect of bifidobacterium administration in postoperative patients with esophageal cancerJPRN-UMIN000048189agoya City University Graduate School of Medical Sciences15
Recruiting
Phase 3
Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network StudyACTRN12621000792820Princess Alexandra Hospital34
Not yet recruiting
Not Applicable
Exploratory study of the effect on gut microbiota by ingestion of oligosaccharide.Healthy adultJPRN-UMIN000052735Meiji Co., Ltd.49
Completed
Phase 1
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteersPharmacokinetic trial in healthy volunteersDRKS00032072niversitätsklinikum Heidelberg, Im Wege der Auftragsverwaltung für die Universität Heidelberg, Medizinische Fakultät Heidelberg20
Recruiting
Not Applicable
Exploring the modulatory effects of gut microbiota on cholangiocarcinoma progression in a patient-derived organoid modelCholangiocarcinomaC22.1Intrahepatic bile duct carcinomaDRKS00033188nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie20